Back to search

A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma

Multiple Myeloma
Clinicaltrials.gov:
EU CTIS:
#2023-507989-76-00
Other:
#64407564MMY2008
Subscribe or share this trial
Countries:
  • Australia,
  • United States
Loading...
Heidelberg, Australia, 3084
Detroit, Michigan, United States, 48201
New York, New York, United States, 10029
Louisville, Kentucky, United States, 40207
Melbourne, Australia, 3000
Camperdown, Australia, 2050
Melbourne, Australia, 3004
Iowa City, Iowa, United States, 52242
Philadelphia, Pennsylvania, United States, 19104
#
More than 50 sites in this region
#
More than 10 sites in this region
#
Less than 10 sites in this region
Map pin icon representing individual study sites
Individual sites
Access detailed information on the trial:
© Johnson & Johnson and its affiliates 2026
J&J Clinical Trials